ArticleAnatolian journal of cardiology2025

Reply to Letter to the Editor: "Critical Appraisal of Isorhamnetin as a Candidate for Pulmonary Arterial Hypertension Treatment".

Yang LiuPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.